Long-term Safety and Efficacy of Nipocalimab: Approximately Two Years Follow-up Results From the Open-label Extension Phase of Vivacity-MG3 Study (P9-9.019)

Carlo Antozzi; Tuan Vu; Sindhu Ramchandren; Richard J. Nowak; Constantine Farmakidis; Vera Bril; Jan De Bleecker; H U I Yang; Eduard Minks; Jin‐Sung Park; Mariusz Grudniak; Marek Smilowski; Teresa Sevilla; Sarah Hoffmann; Kumaraswamy Sivakumar; Panna Sanga; Ibrahim Turkoz; Yaowei Zhu; Marie Fitzgibbon; Michel Burcklen

doi:10.1212/wnl.0000000000212898

Key Points

The aim is to evaluate the long-term safety and efficacy of nipocalimab in treating generalized myasthenia gravis over two years.
Conducted as part of the open-label extension phase of the ongoing Vivacity-MG3 study (NCT04951622)
Follow-up period of approximately two years
Patients diagnosed with generalized myasthenia gravis participated
Demonstrated long-term safety profile with no new safety concerns identified after two years
Efficacy results showed sustained improvement in symptom management for patients over the follow-up period

Implication

Assesses long-term safety and efficacy of nipocalimab in generalized myasthenia gravis, suggesting sustained benefits.

Abstract

To assess the long-term safety and efficacy of nipocalimab in patients with generalized myasthenia gravis (gMG) from the ongoing Vivacity-MG3 (NCT04951622) open-label extension (OLE) phase.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Antozzi et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf36efaef96ed7f055e45 https://doi.org/10.1212/wnl.0000000000212898

View at Publisher

Ask AI

Bookmark

Share

Long-term Safety and Efficacy of Nipocalimab: Approximately Two Years Follow-up Results From the Open-label Extension Phase of Vivacity-MG3 Study (P9-9.019)

Key Points

Implication

Abstract

Discussion

Cite This Study

Long-term Safety and Efficacy of Nipocalimab: Approximately Two Years Follow-up Results From the Open-label Extension Phase of Vivacity-MG3 Study (P9-9.019)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from Neurology

Keep reading

More related papers

More from Neurology